Long COVID Trial, Recruiting NCT05582512 Sponsor: National Taiwan University Hospital Condition: Long COVID
Back to Long Covid

Long COVID Trial, Recruiting

NCT05582512
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have tested positive for COVID-19

Who may not be able to join:

  • People who have metal implants or devices in their body that cannot be removed, such as braces, metal screws, cochlear implants, or heart pacemakers, as these make brain MRI scans unsafe
  • People who have a serious physical illness
  • People who have a sensory impairment, such as deafness
  • People who have a movement disorder, such as cerebral palsy
  • People who have epilepsy that is not currently controlled and stable
  • People who are pregnant, or who are unsure whether they are pregnant (the trial site asks that this be disclosed to the researcher in advance so that a pregnancy test can be arranged)
  • People who have experienced a lack of oxygen to the brain due to encephalitis or any other cause not related to enterovirus infection

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Luna-Yin Chang, professor, National Taiwan University Hospital

Phone: +886 2312 3456

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 July 2022
Est. completion
1 December 2027

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

risk factor and complication; Multidimensional Fatigue Inventory, MFI)-20; seropositive rate of COVID-19

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov